Galapagos Genomics Dividend yield




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   EUR per share 
 Price  201.50
 Dividend  0.00
 Earnings  2.35
 Cash-flow  46.86
 Book value  44.78
 Equity  31.76

Galapagos Genomics is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Galapagos Genomics is a company from Netherlands, and his stocks are publicly traded.

Galapagos Genomics paid a total dividend of 0 million EUR last year, for a market value of 13,098 millions (Market Cap 10,039 millions). Dividend per share of Galapagos Genomics is 0.00 EUR, and his stock market price 201.50 EUR.

According to the chart below where dividend yield is displayed, Galapagos Genomics, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from Netherlands, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Galapagos Genomics might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Galapagos Genomics dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Netherlands.

Dividend yield of Galapagos Genomics

Galapagos Genomics Dividend Payout

About the ability of Galapagos Genomics to maintain his current dividend of EUR 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Galapagos Genomics payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Galapagos Genomics, compared againt world market average, Netherlands companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Galapagos Genomics payout

Galapagos Genomics Stock performance

Finally, last moth Galapagos Genomics showed a return of 11.30% compared to a worldwide 10.27% average, and a 10.94% of Health Care firms. Over the last year, the company obtained a 97.50% versus a worldwide performance of a -13.38%. More detailed information can be seen in the following graph for Netherlands and Pharmaceuticals and Biotechnology firms.

Galapagos Genomics stock and market return

Next companies

Galaxy Entertainment. Hong-Kong. Consumer Services.

Galp Energia SGPS SA. Portugal. Oil and Gas.

Gamesa. Spain. Oil and Gas.

Gamuda. Malaysia. Industrials.

GANFENG LITHIUM (H). China. Basic Materials.

Gap. USA. Consumer Services.

Previous companies

Gail India. India. Oil and Gas.

G4S. UK. Industrials.

Fuyo General Lease. Japan. Financials.

Fuyao Glass Industry. China. Consumer Goods.

Future Retail. India. Consumer Services.

Future Land Development. China. Consumer Goods.

 

 

All rights reserved

 information advertisement legal

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.